Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0P8NZ
|
||||
Former ID |
DNC013556
|
||||
Drug Name |
H-Dmt-Tic-NH-CH2-Indl
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [529246] | ||
Structure |
Download2D MOL |
||||
Formula |
C30H32N4O3
|
||||
Canonical SMILES |
CC1=CC(=CC(=C1CC(C(=O)N2CC3=CC=CC=C3CC2C(=O)NCC4=CC5=CC<br />=CC=C5N4)N)C)O
|
||||
InChI |
1S/C30H32N4O3/c1-18-11-24(35)12-19(2)25(18)15-26(31)30(37)34-17-22-9-4-3-7-20(22)14-28(34)29(36)32-16-23-13-21-8-5-6-10-27(21)33-23/h3-13,26,28,33,35H,14-17,31H2,1-2H3,(H,32,36)/t26-,28-/m0/s1
|
||||
InChIKey |
WOVWFYGUXKNNEL-XCZPVHLTSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Delta-type opioid receptor | Target Info | Inhibitor | [529246] | |
Mu-type opioid receptor | Target Info | Inhibitor | [529246] | ||
NetPath Pathway | TCR Signaling Pathway | ||||
PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
Enkephalin release | |||||
Opioid proenkephalin pathway | |||||
Opioid proopiomelanocortin pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
Pathway Interaction Database | IL4-mediated signaling events | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.